TITLE

Sequenom cashes chips

AUTHOR(S)
Michael, Adam
PUB. DATE
June 1999
SOURCE
Nature Biotechnology;Jun99, Vol. 17 Issue 6, p519
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Reports that San Diego, California-based company Sequenom Inc. has raised 37 million dollar fund in April 1999 to support the launch of its DNA analysis products. Information about these products to be launched; Increase in share price of the company.
ACCESSION #
8820277

 

Related Articles

  • Epigenomics: Detailed analysis. Bonetta, Laura // Nature;8/7/2008, Vol. 454 Issue 7205, p795 

    The article offers information on the use of several technologies including matrix-assisted laser desorption/ionization time-of-flight (MALDITOF) mass spectrometry from Sequenom Inc. and custom-designed oligonucleotide arrays from Affymetrix Inc. in undertaking epigenome. The mass spectrometry...

  • Sequenom's Offering Adds $85M for its Diagnostic Development. Boggs, Jennifer // BioWorld Today;6/27/2008, Vol. 19 Issue 125, p1 

    The article reports on a public offering of 5.5 million shares priced by Sequenom Inc. to support ongoing development of diagnostic tests using its MassArray DNA analysis platform and other technologies. Proceeds from the public offering will also be used for general corporate purposes. The...

  • Sequenom's Eye on the Future. Davies, Kevin // Bio-IT World;Nov2007, Vol. 6 Issue 9, p12 

    An interview with Sequenom chief security officer (CSO) Charles Cantor about the firm's recovery and future plans is presented. When asked how Sequenom is doing lately, Cantor claims the company is doing much better in terms of revenue and market performance. He reveals the company's long-range...

  • Sequenom to make offer for Exact, despite a rejection.  // Medical Device Daily;1/15/2009, Vol. 13 Issue 9, p3 

    The article highlights the intention of Sequenom to move forward with an exchange offer to acquire Exact Sciences in an all-stock transaction valued at $41 million, even though Exact reported earlier its board has already rejected an acquisition proposal by Sequenom. Under the proposed deal,...

  • About SEQUENOM.  // Biotech Business;Nov2003, Vol. 16 Issue 11, p5 

    Provides information on the genetics company SEQUENOM Inc..

  • Financings Roundup.  // BioWorld Today;9/13/2012, Vol. 23 Issue 178, p7 

    The article reports on the launch of a 110 million dollar private offering of convertible senior notes due in 2017 by Sequenom Inc.

  • Financings roundup.  // Medical Device Daily;5/13/2010, Vol. 14 Issue 92, p7 

    The article reports on the decision of San Diego, California-based genetic analysis solutions manufacturer Sequenom to issue and sell an aggregate of 12,435,000 shares of its common stock to specific investors.

  • Financings roundup.  // Medical Device Daily;12/6/2010, Vol. 14 Issue 235, p2 

    The article reports that underwriters of the common stock offering of Sequenom exercised their full option to purchase 2.1 million shares.

  • BIOTECH'S BIG DUSTUP. Santini, Laura // Investment Dealers' Digest;4/14/2003, Vol. 69 Issue 15, p26 

    Focuses on the market situation of biotechnology companies in the terms of investment with reference to the case of San Diego, California-based Sequenom Inc. as of April 2003. Decline in the interest of investors in genomics companies; Decrease in underwriting, mergers and acquisition...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics